Antti Haapalinna Selected Research

Antti Haapalinna Research Topics

3	Mydriasis 12/2009 - 11/2003
2	Hypotension (Low Blood Pressure) 01/2021 - 01/2020
2	Pain (Aches) 01/2020 - 01/2005
2	Parkinson Disease (Parkinson's Disease) 02/2004 - 11/2003
1	Bradycardia 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Stroke (Strokes) 03/2015
1	Cognitive Dysfunction 10/2013
1	Schizophrenia (Dementia Praecox) 10/2013
1	Hypothermia 12/2009
1	Tachycardia (Tachyarrhythmias) 12/2008
1	Psychomotor Agitation (Akathisia) 01/2005
1	Epilepsy (Aura) 09/2004
1	Status Epilepticus (Complex Partial Status Epilepticus) 09/2004
1	Substance-Related Disorders (Drug Abuse) 03/2003
1	Dyskinesias (Dyskinesia) 03/2003
1	Brain Ischemia (Cerebral Ischemia) 01/2000
1	Ischemia 01/2000

4	radolmidineIBA 01/2021 - 12/2008
3	atipamezoleIBA 01/2005 - 11/2003
2	Analgesics (Analgesic Drugs)IBA 01/2020 - 12/2009
2	Clonidine (ST 155)FDA LinkGeneric 01/2020 - 12/2009
2	Dexmedetomidine FDA Link 12/2009 - 12/2008
2	Levodopa (L Dopa)FDA LinkGeneric 02/2004 - 11/2003
2	Dopamine Agents (Dopaminergic Agents)IBA 11/2003 - 03/2003
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2020
1	Valsartan (Vals)FDA Link 03/2015
1	Simendan (Levosimendan)IBA 03/2015
1	Dizocilpine Maleate (Dizocilpine)IBA 10/2013
1	ORM-10921IBA 10/2013
1	Phencyclidine (Angel Dust)IBA 10/2013
1	Biogenic Amines (Biogenic Amine)IBA 12/2009
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 02/2004
1	LigandsIBA 02/2004
1	Apomorphine FDA Link 11/2003
1	IdazoxanIBA 11/2003
1	Dopamine (Intropin)FDA LinkGeneric 03/2003
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2003
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 03/2003
1	Serotonin (5 Hydroxytryptamine)IBA 01/2000
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2000

1	Spinal Anesthesia 01/2021